Cytosorbents Corporation CTSO
Set alert
4.54 USD 0.00 -0.11%
At close · Oct 30
4.54 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
4.35 Day range 4.70
3.06 52-week range 16.74
- YTD
- -64.48%
- 1 year
- -70.97%
- Open
- 4.39
- Prev close
- 4.54
- Mkt cap
- 14.31M
- Vol
- 24.11K
- Avg vol
- 33.22K
- EPS
- -5.80
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.35
- High
- 4.70
- Forward P/E
- -5.99
- Beta
- 0.56
- Short ratio
- 9.57
- Inst. own
- 33.29%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.95762
- 200-d avg
- 0.981655
- 1y target
- 5.00
Financial health
Altman Z-Score
-12.27 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -4.9×
FY 2016 5y median -2.4× FY 2025
P/S 1.1×
FY 2016 5y median 1.6× FY 2025
P/B 6.7×
FY 2016 5y median 2.9× FY 2025
P/FCF -3.2×
FY 2016 5y median -3.2× FY 2025
EV/EBITDA -14.4×
FY 2016 5y median -3.8× FY 2025
EV/Sales 1.7×
FY 2016 5y median 1.8× FY 2025
FCF Yield -31.5%
FY 2016 5y median -31.5% FY 2025
Profitability
Gross Margin 71.5%
FY 2016 5y median 70.6% FY 2025
Operating Margin -38.4%
FY 2016 5y median -56.7% FY 2025
Net Margin -22.1%
FY 2016 5y median -61.2% FY 2025
ROE -138.9%
FY 2016 5y median -125.7% FY 2025
ROIC -38.8%
FY 2016 5y median -40.0% FY 2025
ROA -18.6%
FY 2016 5y median -43.7% FY 2025
Growth (YoY)
Revenue 4.1%
FY 2016 FY 2025
Operating Income 13.5%
FY 2016 FY 2025
EPS (diluted) 65.8%
FY 2016 FY 2025
Free Cash Flow 14.8%
FY 2016 FY 2025
Financial Health
Current Ratio 2.1×
FY 2016 5y median 2.2× FY 2025
Quick Ratio 1.6×
FY 2016 5y median 1.9× FY 2025
Debt / Equity 4.9×
FY 2016 5y median 0.8× FY 2025
Net Debt / EBITDA -5.2×
FY 2016 5y median -0.2× FY 2025
Interest Coverage -5.5×
FY 2016 5y median -5.5× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31